reviewCancer ResearchNov 1, 2004Closed access

Aberrant and Alternative Splicing in Cancer

Centre for Life · Newcastle University

PubMed
Indexed incrossrefpubmed

Abstract

Pre-mRNA splicing is a sophisticated and ubiquitous nuclear process, which is a natural source of cancer-causing errors in gene expression. Intronic splice site mutations of tumor suppressor genes often cause exon-skipping events that truncate proteins just like classical nonsense mutations. Also, many studies over the last 20 years have reported cancer-specific alternative splicing in the absence of genomic mutations. Affected proteins include transcription factors, cell signal transducers, and components of the extracellular matrix. Antibodies against alternatively spliced products on cancer cells are currently in clinical trials, and competitive reverse transcription-PCR across regions of alternative…

Citation impact

635
total citations
FWCI
13.50
Percentile
100%
References
102
Citations per year

Authors

1

Topics & keywords

Keywords
  • RNA splicing
  • Alternative splicing
  • Exon
  • Biology
  • Exon skipping
  • Genetics
  • Gene
  • Post-transcriptional modification
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.